Grant: HIV/AIDS & STBBI Clinical Trials Research Network - Phase 1
Research Institute of the McGill University Health Centre
$25,000,000.00
CIHR Pan-Canadian Network for HIV/AIDS and Sexually Transmitted and Blood Borne Infections (STBBI) Clinical Trials Research (CTN)
EF 2023-24
Résumé
Over 30 years, the CIHR Canadian HIV Trials Network (CTN) has built a world-class national network enabling Canadian researchers, healthcare providers and community members to collaborate locally and internationally to lead impactful, outcomes-based clinical research in HIV, hepatitis C, syphilis and other sexually transmitted and blood-borne infections (STBBIs) and train the next generation of researchers. Despite tremendous progress, important disparities across regions and populations remain. There are also many opportunities to develop new technologies, models of care and curative therapies. Aligned with the CIHR HIV/AIDS and STBBI Research Initiative, we present our proposal to restructure the CTN. At its foundation are five Interdisciplinary Clinical Trials Research Teams (Atlantic, Quebec, Ontario, Prairies, and British Columbia/Yukon) that will respond to local priorities, ensure meaningful community engagement, and offer equitable access to research for all populations. We will foster innovative pan-Canadian trials through science accelerators focused on Prevention, Treatment/Management, and Cure, informed by regional teams and people with lived/living experience including Indigenous groups. A National Coordinating Centre will provide critical infrastructure to promote network objectives and accelerate research. A Community-Centred Knowledge Mobilization (KM) Hub will support all CTN members to create high-quality, effective KM products to share research outputs using culturally safe approaches to diverse stakeholders. Strong governance will ensure equity, diversity and inclusion in decision making and engagement with national and international networks. Building on a track record of success, the reimagined CTN+ will strengthen capacity for STBBI trials in Canada, mobilize research knowledge among stakeholders, improve health equity for marginalized populations, and meaningfully advance commitments towards Truth and Reconciliation with Indigenous Peoples.
Programme
HIV/AIDS & STBBI Clinical Trials Research Network - Phase 1
Emplacement
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
495600
Name
Klein Marina B
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Clinical
Prcname2
HIV/AIDS & STBBI Clinical Trials Research Network - Phase 1
Projecttitle
CIHR Pan-Canadian Network for HIV/AIDS and Sexually Transmitted and Blood Borne Infections (STBBI) Clinical Trials Research (CTN)
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$25,000,000
Cihrequipment2
$0
Programname2
HIV/AIDS & STBBI Clinical Trials Research Network - Phase 1
Keyworddelim
Clinical Trials; Community Engaged; Cure; Hepatitis B And C; Hiv/Aids; Network; Prevention; Sexually Transmitted And Blood Borne Infections; Syphilis; Treatment
Abstract
Over 30 years, the CIHR Canadian HIV Trials Network (CTN) has built a world-class national network enabling Canadian researchers, healthcare providers and community members to collaborate locally and internationally to lead impactful, outcomes-based clinical research in HIV, hepatitis C, syphilis and other sexually transmitted and blood-borne infections (STBBIs) and train the next generation of researchers. Despite tremendous progress, important disparities across regions and populations remain. There are also many opportunities to develop new technologies, models of care and curative therapies. Aligned with the CIHR HIV/AIDS and STBBI Research Initiative, we present our proposal to restructure the CTN. At its foundation are five Interdisciplinary Clinical Trials Research Teams (Atlantic, Quebec, Ontario, Prairies, and British Columbia/Yukon) that will respond to local priorities, ensure meaningful community engagement, and offer equitable access to research for all populations. We will foster innovative pan-Canadian trials through science accelerators focused on Prevention, Treatment/Management, and Cure, informed by regional teams and people with lived/living experience including Indigenous groups. A National Coordinating Centre will provide critical infrastructure to promote network objectives and accelerate research. A Community-Centred Knowledge Mobilization (KM) Hub will support all CTN members to create high-quality, effective KM products to share research outputs using culturally safe approaches to diverse stakeholders. Strong governance will ensure equity, diversity and inclusion in decision making and engagement with national and international networks. Building on a track record of success, the reimagined CTN+ will strengthen capacity for STBBI trials in Canada, mobilize research knowledge among stakeholders, improve health equity for marginalized populations, and meaningfully advance commitments towards Truth and Reconciliation with Indigenous Peoples.
Competitiondate
202402
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Klein, Marina B; Habanyama, Muluba; Mandarino, Enrico; Martin, Carrie; Angel, Jonathan B; Anis, Aslam H; Brophy, Jason C; Burchell, Ann N; Coffin, Carla S; Costiniuk, Cecilia T; Daley, Peter; Durand, Madeleine; Fontaine, Guillaume; Golchi, Shirin; Grennan, Jonathan (Troy); Hart, Trevor A; Hull, Mark W; Keynan, Yoav; King, Elizabeth M; Kronfli, Nadine; Law, John Lok Man; Lebouché, Bertrand; Logie, Carmen; Mbuagbaw, Lawrence C; McGuinty, Michaeline; Murray, Melanie C; Shaw, Souradet Y; Smyth, Daniel J; Spence, Cara J; Tan, Darrell H; Walmsley, Sharon L; Wong, Alexander C; Worthington, Catherine A; Zhabokritsky, Alice
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $25,000,000~ $0~